Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Guardant Health to Participate in Upcoming Investor Conferences
-
AdaptHealth Corp. to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
GreenEnergyBreaks — Exro Technologies Inc.’s (TSX: EXRO) (OTCQB: EXROF) Execs to Participate at This Month’s Canaccord Genuity 44th Annual Growth Conference
-
Firm Capital Mortgage Investment Corporation Completes $22 Million Bought Deal Financing
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
-
Geneoscopy’s CEO Andrew Barnell to Present at Upcoming Investor Conferences
-
Arq to Attend Upcoming Investor Conferences
-
electroCore to Participate in Upcoming Investor Conferences
-
Ocuphire Pharma to Present at Two Investor Conferences in August
-
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
-
Canaccord Genuity Starts Tandem Diabetes Care (TNDM) at Buy
-
Canaccord Genuity Starts Fresnillo Plc. (FRES:LN) (FNLPF) at Buy
-
Valeura Energy Inc. Announces Second Quarter 2024 Results
-
Exro to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
-
ACV Announces Participation in Upcoming Investor Conferences
-
EverQuote to Participate in Upcoming Investor Conferences
-
MediaAlpha to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Blend to Participate in The Canaccord Genuity 44th Annual Growth Conference
-
EZCORP to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference
-
Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Lyft (LYFT) PT Lowered to $18 at Canaccord Genuity
-
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference
-
Zevra Therapeutics to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Qualys to Speak at Upcoming Investor Conference
-
ZoomInfo to Participate in Upcoming Investor Conferences
-
Revolo Announces Fireside Chat at Canaccord Genuity’s 44th Annual Growth Conference
-
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
-
Innovid to Participate in Upcoming Investor Conferences
-
Immutep to Participate in Upcoming Investor Conferences
-
ON24 to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Unisys (UIS) PT Lowered to $4.25 at Canaccord Genuity
-
Y-mAbs to Participate in Upcoming Investor Conferences in August
-
Vivid Seats Inc. (SEAT) PT Lowered to $8 at Canaccord Genuity
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $77 at Canaccord Genuity
-
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
BioXcel Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $38 at Canaccord Genuity
-
Qualys (QLYS) PT Lowered to $160 at Canaccord Genuity
-
Nevro Corp (NVRO) PT Lowered to $8 at Canaccord Genuity
-
Hudson Technologies (HDSN) PT Lowered to $8.75 at Canaccord Genuity
-
Eve Holding Inc. (EVEX) PT Lowered to $7 at Canaccord Genuity

